Though downsized, Alumis still clocked one of the largest IPOs within the biotec...
Holoclara has secured $16m in a Series A financing to advance new worm-derived t...
Eisai and Biogen have announced the introduction of LEQEMBI (lecanemab) for the ...
Nearly 200 people have been charged with participating in healthcare fraud schem...
The US Supreme Court blocked $6bn opioid crisis settlement that would have shiel...
NovoNordisk acquired the hypertension and kidney disease drug ocedurenone from K...
The US FDA has provided a complete response letter for Daiichi Sankyo and MSD’s ...
AbbVie has announced the receipt of accelerated approval from the US FDA for EPK...
As the funding market evolves, there is greater emphasis on companies having com...
US-based 2seventy bio has completed an asset purchase agreement (APA) to divest ...
Ohtuvayre is expected to rake in $1.1bn in global sales from the market for COPD...
The recent raise will bring the biotech accelerator Curie.Bio’s total funds rais...
Data showed that Ohtuvayre significantly improved dyspnea compared to placebo in...
Formation Bio has secured $372m in Series D funding to bolster its drug pipeline...
The CDC ACIP has recommended the routine use of respiratory syncytial virus (RSV...
ETH47 is a type III interferon-encoding mRNA drug that could be used to treat re...
